Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,025 EUR | +0,50% | -1,48% | +28,21% |
07/05 | Koersdoel AstraZeneca verhoogd; Antofagasta verlaagd | AN |
03/05 | AIB GROUP : Sterkere inkomstengroei en gunstige risicokosten |
Omzet 2024 * | 4,56 mld. 4,95 mld. | Omzet 2025 * | 4,34 mld. 4,72 mld. | Marktkapitalisatie | 12,13 mld. 13,19 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,76 mld. 1,92 mld. | Nettowinst (verlies) 2025 * | 1,56 mld. 1,7 mld. | EV/omzet 2024 * | 2,66 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 2,79 x |
K/w-verhouding 2024 * |
6,99
x | K/w-verhouding 2025 * |
7,27
x | Werknemers | - |
Dividendrendement 2024 * |
6% | Dividendrendement 2025 * |
6,36% | Vrij verhandelbaar | 67,6% |
Recentste transcriptie over AIB Group plc
1 week | -1,48% | ||
Lopende maand | +0,93% | ||
1 maand | +2,38% | ||
3 maanden | +25,00% | ||
6 maanden | +17,54% | ||
Lopend jaar | +28,21% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Colin Hunt
CEO | Chief Executive Officer | 54 | 01-01-16 |
Donal Galvin
DFI | Director of Finance/CFO | 50 | 01-09-13 |
Graham Fagan
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Fergal O’Dwyer
BRD | Director/Board Member | 64 | 22-01-21 |
James Pettigrew
CHM | Chairman | 65 | 28-10-21 |
Brendan McDonagh
BRD | Director/Board Member | 66 | 27-10-16 |
Datum | Koers | Variatie |
---|---|---|
16-05-24 | 5,025 | +0,50% |
15-05-24 | 5 | +0,28% |
14-05-24 | 4,986 | -0,08% |
13-05-24 | 4,99 | +0,16% |
10-05-24 | 4,982 | +0,73% |
Real Time BOERSE MUENCHEN, 16 mei 2024 om 11:13 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,82% | 333 mld. | |
+15,56% | 304 mld. | |
+23,30% | 251 mld. | |
+26,66% | 217 mld. | |
+26,88% | 180 mld. | |
+29,87% | 169 mld. | |
+11,52% | 165 mld. | |
+7,10% | 149 mld. | |
-15,09% | 131 mld. |